financetom
Business
financetom
/
Business
/
What's Going On With Coinbase Shares Friday?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Coinbase Shares Friday?
Jul 26, 2024 10:09 AM

Coinbase Global, Inc. ( COIN ) stock is moving higher on Friday following a rise in the price of Bitcoin (CRYPTO: BTC) above $67,000.

What To Know: Bitcoin is currently trading approximately 2.5% higher at $67,506 per data from Benzinga Pro.

Coinbase is trading at $239.65, a bit above its 50 day moving average of $233.06. It’s trading towards the lower end of its 52 week range which is from $237.56 to $249.16. The stock’s average session volume is 8.54 million which its trading below at 4.27 million.

Other crypto-linked stocks, such as Riot Platforms, Inc. ( RIOT ) and CleanSpark, Inc. ( CLSK ) , are also moving higher following the rise in the price of Bitcoin.

Coinbase is expected to report earnings on Thursday after the market closes. Analysts estimate an EPS of 94 cents and revenue of $1.40 billion. Earlier this week, Citigroup analyst Peter Christiansen upgraded Coinbase Glb from Neutral to Buy and raised the price target from $260 to $345.

How To Buy Coinbase Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Coinbase Glb 's case, it is in the Financials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

See Also: Dogecoin’s Price Increased More Than 4% Within 24 hours

COIN Price Action: Coinbase shares are trading 4.4% higher at $241.74, according to data from Benzinga Pro.

Image: Photo by rafapress on Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Fisker seeks judge's approval to sell Ocean EVs at $14,000 per SUV
Fisker seeks judge's approval to sell Ocean EVs at $14,000 per SUV
Jul 3, 2024
July 3 (Reuters) - Fisker ( FSRNQ ) has asked a bankruptcy judge overseeing its Chapter 11 proceedings to approve the sale of more than 3,000 Ocean electric SUVs in its inventory for about $14,000 per car to a vehicle-leasing company. Following the judge's nod, Fisker ( FSRNQ ) will be able to offload 3,321 electric vehicles to New York-based...
Whitecap Resources Keeps Outperform Rating, $15 Price Target at National Bank of Canada
Whitecap Resources Keeps Outperform Rating, $15 Price Target at National Bank of Canada
Jul 3, 2024
10:37 AM EDT, 07/03/2024 (MT Newswires) -- Whitecap Resources ( SPGYF ) has kept its Outperform rating and $15 price target after the company completed partial infrastructure dispositions and announced strategic partnerships with Pembina Pipeline ( PBA ) , National Bank of Canada said in a Tuesday note. Whitecap agreed to sell 50% of its Musreau facility to Topaz Energy...
Update on Aya Gold & Silver; Zgounder's ESG Platform Gets Tailwinds from Windfarm-Sourced Grid, notes National Bank
Update on Aya Gold & Silver; Zgounder's ESG Platform Gets Tailwinds from Windfarm-Sourced Grid, notes National Bank
Jul 3, 2024
10:59 AM EDT, 07/03/2024 (MT Newswires) -- Aya Gold & Silver ( AYASF ) said on Wednesday that it has completed the commissioning of its electrical line and started providing power to its Zgounder Silver Mine in Morocco with renewable energy. The 20-year power purchase agreement with Nareva's Energie Eolienne du Maroc, and access to the national high-voltage grid, is...
Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
Jul 3, 2024
10:14 AM EDT, 07/03/2024 (MT Newswires) -- Insmed ( INSM ) is scheduled to disclose additional positive results from a phase 3 trial of its brensocatib drug candidate in patients with non-cystic fibrosis bronchiectasis on Thursday at a medical conference in Dundee, Scotland, it said. The company will present data at the World Bronchiectasis Conference showing patients in 10- and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved